|
 |
|
|||||||
|
|||||||||
© 2001 by the American Diabetes Association, Inc.
Pathophysiology/Complications |
Anemia With Erythropoietin Deficiency Occurs Early in Diabetic Nephropathy
1 King’s Diabetes Centre
2 Department of Biochemistry, and the
3 Department of Renal Medicine, King’s College Hospital, London, U.K.
OBJECTIVE—The normochromic normocytic anemia of erythropoietin (EPO) deficiency is recognized in advanced renal failure but not in early renal disease. The aim of this study was to determine whether anemia with EPO deficiency is found in type 1 diabetic patients with diabetic nephropathy in the absence of advanced renal failure and to compare them with patients with nondiabetic renal disease of similar severity.
RESEARCH DESIGN AND METHODS—A total of 27 type 1 diabetic patients with diabetic nephropathy (DN), defined as having persistent proteinuria (mean 1,086 mg/day [CI 120–5,190]), a serum creatinine 
180 µmol/l, and retinopathy, were compared with 26 nondiabetic patients with glomerulonephritis (GN) and persistent proteinuria (1,874 mg/day [349–5,005]). The Hb concentration, red cell indexes, and serum EPO levels were measured, and other causes for the anemia were excluded. The EPO values were compared with a normal reference range obtained from nondiabetic patients with a microcytic anemia. The DN patients were tested for signs of diabetic peripheral and autonomic neuropathy.
RESULTS—We found that 13 of the 27 DN patients were anemic (Hb 10.6 ± 0.9 g/dl) in marked contrast to none of the GN patients (Hb 13.7 ± 1.4 g/dl, P < 0.005). In the DN group, serum EPO concentrations failed to increase in response to anemia compared with the response seen in patients with microcytic anemia. Thus, the anemia of the DN group was associated with EPO deficiency. The anemic DN patients showed evidence of more severe proteinuria and diabetic neuropathy than the nonanemic DN patients.
CONCLUSIONS—Anemia associated with EPO deficiency can occur early in DN before the onset of advanced renal failure, but does not normally occur in nondiabetic renal disease of similar severity. The pathogenesis requires elucidation.
Abbreviations: DN, diabetic nephropathy • EPO, erythropoietin • GN, glomerulonephritis • PH, postural hypotension
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Joss, R. Patel, K. Paterson, K. Simpson, C. Perry, and C. Stirling Anaemia is common and predicts mortality in diabetic nephropathy QJM, October 1, 2007; 100(10): 641 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Horl, Y. Vanrenterghem, P. Aljama, P. Brunet, R. Brunkhorst, L. Gesualdo, I. Macdougall, C. Wanner, and B. Wikstrom OPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD) Nephrol. Dial. Transplant., June 1, 2007; 22(suppl_3): iii20 - iii26. [Full Text] [PDF]
|
|
|
|
|
|
A. Inoue, T. Babazono, K. Suzuki, and Y. Iwamoto Albuminuria is an independent predictor of decreased serum erythropoietin levels in type 2 diabetic patients Nephrol. Dial. Transplant., January 1, 2007; 22(1): 287 - 288. [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Vlagopoulos, H. Tighiouart, D. E. Weiner, J. Griffith, D. Pettitt, D. N. Salem, A. S. Levey, and M. J. Sarnak Anemia as a Risk Factor for Cardiovascular Disease and All-Cause Mortality in Diabetes: The Impact of Chronic Kidney Disease J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3403 - 3410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Craig, J. D. Williams, S. G. Riley, H. Smith, D. R. Owens, D. Worthing, I. Cavill, and A. O. Phillips Anemia and Diabetes in the Absence of Nephropathy Diabetes Care, May 1, 2005; 28(5): 1118 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Shibao, A. Gamboa, A. Diedrich, and I. Biaggioni Management of Hypertension in the Setting of Autonomic Failure: A Pathophysiological Approach Hypertension, April 1, 2005; 45(4): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Thomas, M. E. Cooper, C. Tsalamandris, R. MacIsaac, and G. Jerums Anemia With Impaired Erythropoietin Response in Diabetic Patients Arch Intern Med, February 28, 2005; 165(4): 466 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Thomas, R. J. MacIsaac, C. Tsalamandris, L. Molyneaux, I. Goubina, G. Fulcher, D. Yue, and G. Jerums The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1792 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jacob, F. Costa, and I. Biaggioni Spectrum of Autonomic Cardiovascular Neuropathy in Diabetes Diabetes Care, July 1, 2003; 26(7): 2174 - 2180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Thomas, R. J. MacIsaac, C. Tsalamandris, D. Power, and G. Jerums Unrecognized Anemia in Patients With Diabetes: A cross-sectional survey Diabetes Care, April 1, 2003; 26(4): 1164 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Silverberg, D. Wexler, M. Blum, J. Z. Tchebiner, D. Sheps, G. Keren, D. Schwartz, R. Baruch, T. Yachnin, M. Shaked, et al. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron Nephrol. Dial. Transplant., January 1, 2003; 18(1): 141 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Winkler, S. Landau, and P. J. Watkins Erythropoietin Treatment of Postural Hypotension in Anemic Type 1 Diabetic Patients With Autonomic Neuropathy: A case study of four patients Diabetes Care, June 1, 2001; 24(6): 1121 - 1123. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |